{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T22:51:19Z","timestamp":1784760679648,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","award":["ECF181561"],"award-info":[{"award-number":["ECF181561"]}],"id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001102","name":"Cancer Council New South Wales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1159491"],"award-info":[{"award-number":["APP1159491"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1194679"],"award-info":[{"award-number":["APP1194679"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.vaccine.2025.126986","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T03:42:01Z","timestamp":1742010121000},"page":"126986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Predicted impact of HPV vaccination and primary HPV screening on precancer treatment rates and adverse pregnancy outcomes in Australia 2010\u20132070: Modelling in a high income, high vaccination coverage country with HPV-based cervical screening"],"prefix":"10.1016","volume":"54","author":[{"given":"Susan","family":"Yuill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela T.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Caruana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gigi","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louiza S.","family":"Velentzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. David","family":"Wrede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Bateson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Canfell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.126986_bb0005","author":"Cancer Council Australia Cervical Cancer Screening Guidelines Working Party"},{"key":"10.1016\/j.vaccine.2025.126986_bb0010","series-title":"The National Centre for Immunisation Research and Surveillance (NCIRS). Annual Immunisation Coverage Report 2021","year":"2022"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126986_bb0015","doi-asserted-by":"crossref","first-page":"262","DOI":"10.5694\/mja16.00958","article-title":"HPV vaccine coverage is increasing in Australia","volume":"206","author":"Brotherton","year":"2017","journal-title":"Med J Aust"},{"issue":"23","key":"10.1016\/j.vaccine.2025.126986_bb0020","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1016\/j.vaccine.2018.04.080","article-title":"Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program","volume":"36","author":"Garland","year":"2018","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2025.126986_bb0025","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1093\/infdis\/jiy075","article-title":"Very Low Prevalence of Vaccine Human Papillomavirus Types among 18- to 35-year Old Australian Women 9 years Following Implementation of Vaccination","volume":"217","author":"Machalek","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126986_bb0030","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.vaccine.2018.11.075","article-title":"Age-specific HPV prevalence among 116,052 women in Australia\u2019s renewed cervical screening program: A new tool for monitoring vaccine impact","volume":"37","author":"Brotherton","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126986_bb0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/infdis\/jiu370","article-title":"Fall in genital warts diagnoses in the general and indigenous Australian population following implementation of a national human papillomavirus vaccination program: analysis of routinely collected national hospital data","volume":"211","author":"Smith","year":"2015","journal-title":"J Infect Dis"},{"issue":"9783","key":"10.1016\/j.vaccine.2025.126986_bb0040","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(11)60551-5","article-title":"Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study","volume":"377","author":"Brotherton","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.126986_bb0045","doi-asserted-by":"crossref","first-page":"3056407","DOI":"10.1155\/2016\/3056407","article-title":"Excisional Treatment of Cervical Dysplasia in Australia 2004-2013: A Population-Based Study","volume":"2016","author":"Robertson","year":"2016","journal-title":"J Oncol"},{"key":"10.1016\/j.vaccine.2025.126986_bb0050","article-title":"Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study","volume":"11(1):227","author":"Gertig","year":"2013","journal-title":"BMC Med"},{"issue":"7948","key":"10.1016\/j.vaccine.2025.126986_bb0055","first-page":"14","article-title":"Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia","volume":"348","author":"Crowe","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2025.126986_bb0060","series-title":"Cervical screening in Australia 2019. Cancer Series no. 123. Cat. no. CAN 124. Canberra","author":"Australian Institute of Health and Welfare (AIHW)","year":"2019"},{"key":"10.1016\/j.vaccine.2025.126986_bb0065","series-title":"National Cervical Screening Program monitoring report 2022. Cat. no. CAN 149. Canberra: AIHW","author":"Australian Institute of Health and Welfare (AIHW)","year":"2022"},{"key":"10.1016\/j.vaccine.2025.126986_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.pvr.2019.100177","article-title":"Is one dose of human papillomavirus vaccine as effective as three?: A national cohort analysis","volume":"8","author":"Brotherton","year":"2019","journal-title":"Papillomavirus Res"},{"issue":"9509","key":"10.1016\/j.vaccine.2025.126986_bb0075","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","article-title":"Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis","volume":"367","author":"Kyrgiou","year":"2006","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126986_bb0080","article-title":"Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease (Review)","author":"Kyrgiou","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126986_bb0085","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/infdis\/jiaa054","article-title":"Association Between Maternal Human Papillomavirus Infection and Adverse Pregnancy Outcomes: Systematic Review and Meta-analysis","volume":"221","author":"Niyibizi","year":"2020","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2025.126986_bb0090","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1080\/21645515.2021.1936860","article-title":"The impact of HPV vaccination beyond cancer prevention: effect on pregnancy outcomes","volume":"17","author":"Yuill","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126986_bb0095","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/ijc.30926","volume":"141","author":"Velentzis","year":"2017","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126986_bb0100","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/infdis\/jiaa106","article-title":"Has HPV vaccination prevented adverse pregnancy outcomes? Population level analysis after eight years of a national HPV vaccination program in Australia","volume":"222","author":"Yuill","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126986_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106473","article-title":"Preterm birth rate after bivalent HPV vaccination: registry-based follow-up of a randomized clinical trial","volume":"146","author":"Kalliala","year":"2021","journal-title":"Prev Med"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126986_bb0110","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/1471-0528.17349","article-title":"Spontaneous preterm birth risk among HPV-vaccinated and -unvaccinated women: a nationwide retrospective cohort study of over 240000 singleton births","volume":"130","author":"McClymont","year":"2023","journal-title":"BJOG"},{"key":"10.1016\/j.vaccine.2025.126986_bb0115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ejogrb.2021.05.037","article-title":"Has the human papillomavirus (HPV) immunization programme improved obstetric outcomes in spontaneous delivery? An ecological study","volume":"262","author":"Xu","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126986_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185332","article-title":"Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017-2035: Example from Australia","volume":"13","author":"Hall","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126986_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djw216","article-title":"Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus","volume":"109","author":"Kim","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.vaccine.2025.126986_bb0130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejca.2017.12.018","article-title":"Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines","volume":"91","author":"Pedersen","year":"2018","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1016\/j.vaccine.2025.126986_bb0135","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1002\/ijc.30392","article-title":"Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries","volume":"139","author":"Simms","year":"2016","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126986_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145548","article-title":"Cervical Cancer Screening in Partly HPV Vaccinated Cohorts - A Cost-Effectiveness Analysis","volume":"11","author":"Naber","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2025.126986_bb0145","series-title":"In: In: Department of Health AG, editor, editor","article-title":"National Cervical Screening Program Renewal: Effectiveness modelling and economic evaluation in the Australian setting (Assessment Report)","author":"Lew","year":"2013"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126986_bb0150","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1016\/S2468-2667(17)30007-5","article-title":"Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program","volume":"2","author":"Lew","year":"2017","journal-title":"Lancet Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126986_bb0155","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/S2468-2667(18)30183-X","article-title":"The projected timeframe until cervical cancer elimination in Australia: a modelling study","volume":"4","author":"Hall","year":"2019","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.vaccine.2025.126986_bb0160","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12913-016-1375-9","article-title":"Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use","volume":"16","author":"Smith","year":"2016","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126986_bb0165","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.vaccine.2013.11.075","article-title":"Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: independent estimates from a nationally representative mobile phone survey","volume":"32","author":"Brotherton","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126986_bb0170","author":"National HPV Vaccination Program Register"},{"key":"10.1016\/j.vaccine.2025.126986_bb0175","author":"Victorian Cervical Cytology Registry (VCCR)"},{"key":"10.1016\/j.vaccine.2025.126986_bb0180","series-title":"Estimated Resident Population By Single Year of Age, 1970\u20132010, Australia","article-title":"3101.0 Australian Demographic Statistics","author":"Australian Bureau of Statistics (ABS)","year":"2013"},{"key":"10.1016\/j.vaccine.2025.126986_bb0200","series-title":"Australia's mothers and babies 2016\u2014in brief. Australian Government","author":"Australian Institute of Health and Welfare (AIHW)","year":"2018"},{"key":"10.1016\/j.vaccine.2025.126986_bb0205","series-title":"3222.0 Population Projections, Australia. Series B Population Projections by Age and Sex","author":"Australian Bureau of Statistics (ABS)","year":"2013"},{"issue":"4","key":"10.1016\/j.vaccine.2025.126986_bb0210","first-page":"709","article-title":"What cervical screening is appropriate for women who have been vaccinated against high risk HPV?","volume":"142","author":"Landy","year":"2018","journal-title":"A simulation study.\u00a0 Int J Cancer"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126986_bb0215","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s12916-022-02631-7","article-title":"Rapid elimination of cervical cancer while maintaining the harms and benefits ratio of cervical cancer screening: a modelling study","volume":"20","author":"Jansen","year":"2022","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126986_bb0220","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12916-023-02748-3","article-title":"Maximizing the cost-effectiveness of cervical screening in the context of routine HPV vaccination by optimizing screening strategies with respect to vaccine uptake: a modeling analysis","volume":"21","author":"Choi","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2025.126986_bb0225","author":"National Health and Medical Research Council (NHMRC)"},{"key":"10.1016\/j.vaccine.2025.126986_bb0230","article-title":"Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis","volume":"354","author":"Kyrgiou","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2025.126986_bb0235","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/1471-0528.13839","article-title":"Risk of preterm birth following surgical treatment for cervical disease: executive summary of a recent symposium","volume":"123","author":"Sasieni","year":"2016","journal-title":"BJOG"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126986_bb0245","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S1470-2045(22)00334-5","article-title":"Comparative effectiveness and risk of preterm birth of local treatments for cervical intraepithelial neoplasia and stage IA1 cervical cancer: a systematic review and network meta-analysis","volume":"23","author":"Athanasiou","year":"2023","journal-title":"Lancet Oncol"}],"updated-by":[{"DOI":"10.1016\/j.vaccine.2025.127079","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000}}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2500283X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2500283X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T14:21:07Z","timestamp":1750342867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2500283X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":45,"alternative-id":["S0264410X2500283X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126986","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.vaccine.2025.127079","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicted impact of HPV vaccination and primary HPV screening on precancer treatment rates and adverse pregnancy outcomes in Australia 2010\u20132070: Modelling in a high income, high vaccination coverage country with HPV-based cervical screening","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126986","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126986"}}